Literature DB >> 1853735

Gender and schizophrenia: age at onset and sociodemographic attributes.

O Gureje1.   

Abstract

A consecutive series of 214 patients (125 males, 89 females) who met the Research Diagnostic Criteria for schizophrenia were studied to determine gender differences in age at onset of the illness and sociodemographic attributes. The immediate family's first awareness of psychotic symptoms or signs and age at first presentation in hospital were used as indices of onset; male patients had a significantly earlier age of onset than females. By the time they were 30 years of age, 83% of male patients had already become ill and only 66% of females had done so. Significantly more females than males were married at the time of first contact with hospital. Married males did not differ from married females in age at onset of illness, suggesting that patients who marry may have late onset.

Entities:  

Mesh:

Year:  1991        PMID: 1853735     DOI: 10.1111/j.1600-0447.1991.tb05564.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  11 in total

1.  Socio-demographic correlates of treatment response among patients with schizophrenia in a tertiary hospital in South-East Nigeria.

Authors:  Mark S Ezeme; Richard Uwakwe; Appolos C Ndukuba; Monday N Igwe; Paul C Odinka; Kennedy Amadi; Nichodemus O Obayi
Journal:  Afr Health Sci       Date:  2016-12       Impact factor: 0.927

2.  Classes of psychotic experiences in Kenyan children and adolescents.

Authors:  Daniel Mamah; Akinkunle Owoso; Anne W Mbwayo; Victoria N Mutiso; Susan K Muriungi; Lincoln I Khasakhala; Deanna M Barch; David M Ndetei
Journal:  Child Psychiatry Hum Dev       Date:  2013-06

3.  Demographic correlates of attenuated positive psychotic symptoms.

Authors:  Rachel N Waford; Allison MacDonald; Katrina Goines; Derek M Novacek; Hanan D Trotman; Walker Elaine F; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Daniel H Mathalon; Ming T Tsuang; Diana O Perkins; Larry J Seidman; Scott W Woods; Thomas H McGlashan
Journal:  Schizophr Res       Date:  2015-05-18       Impact factor: 4.939

4.  The modulation of brain dopamine and GABAA receptors by estradiol: a clue for CNS changes occurring at menopause.

Authors:  R Bossé; T DiPaolo
Journal:  Cell Mol Neurobiol       Date:  1996-04       Impact factor: 5.046

5.  Dopamine and GABAA receptor imbalance after ovariectomy in rats: model of menopause.

Authors:  R Bossé; T Di Paolo
Journal:  J Psychiatry Neurosci       Date:  1995-11       Impact factor: 6.186

6.  Prescription stimulant use is associated with earlier onset of psychosis.

Authors:  Lauren V Moran; Grace A Masters; Samira Pingali; Bruce M Cohen; Elizabeth Liebson; R P Rajarethinam; Dost Ongur
Journal:  J Psychiatr Res       Date:  2015-09-21       Impact factor: 4.791

7.  Gender differences in coerced patients with schizophrenia.

Authors:  Alexander Nawka; Lucie Kalisova; Jiri Raboch; Domenico Giacco; Libor Cihal; Georgi Onchev; Anastasia Karastergiou; Zahava Solomon; Andrea Fiorillo; Valeria Del Vecchio; Algirdas Dembinskas; Andrzej Kiejna; Petr Nawka; Francisco Torres-Gonzales; Stefan Priebe; Lars Kjellin; Thomas W Kallert
Journal:  BMC Psychiatry       Date:  2013-10-11       Impact factor: 3.630

Review 8.  Considering the Microbiome in Stress-Related and Neurodevelopmental Trajectories to Schizophrenia.

Authors:  Kevin W Hoffman; Jakleen J Lee; Cheryl M Corcoran; David Kimhy; Thorsten M Kranz; Dolores Malaspina
Journal:  Front Psychiatry       Date:  2020-07-03       Impact factor: 4.157

9.  Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review.

Authors:  Susana Ochoa; Judith Usall; Jesús Cobo; Xavier Labad; Jayashri Kulkarni
Journal:  Schizophr Res Treatment       Date:  2012-04-08

10.  Neighborhood-level predictors of age at onset and duration of untreated psychosis in first-episode psychotic disorders.

Authors:  Benson S Ku; Luca Pauselli; Marc Manseau; Michael T Compton
Journal:  Schizophr Res       Date:  2020-01-14       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.